Navigation Links
JHP Pharmaceuticals Announces Multi-Year Contract Manufacturing Agreement
Date:3/28/2011

PARSIPPANY, N.J., March 28, 2011 /PRNewswire/ -- JHP Pharmaceuticals, a leading provider of contract manufacturing services for sterile injectable products, has entered into a multi-year contract-manufacturing agreement with an undisclosed biotechnology company. JHP will be responsible for manufacturing and supply of a sterile liquid product used in processing biologics.

Stuart Hinchen, president and co-founder of JHP noted, “We look forward to serving this important customer and see this partnership as another opportunity to demonstrate our customer-centric approach in the manufacture of quality-driven products that improve patient health.”

Commenting on being awarded this contract, the third multi-year contract within a three‐month period, Hinchen stated, “Since the purchase of the Rochester, Michigan manufacturing facility in 2007, we have focused on growing our internal infrastructure to support expansion of our contract manufacturing services. We accomplished this in a short time-period by focusing our investments in two key areas: our people and our facility. Additionally, our record of cGMP compliance, driven by our experienced Quality and Regulatory Teams continue as an important factor to all customers that we serve.”

JHP’s Rochester, Michigan manufacturing site has a solid history of successful partnerships, manufacturing clinical and commercial products.

About JHP Pharmaceuticals, LLC JHP Pharmaceuticals, headquartered in New Jersey, provides contract manufacturing of sterile injectables, biologics, vaccines, ophthalmics and otics for large and small pharmaceutical and biotech organizations.

JHP’s sterile manufacturing facility, located in Rochester Michigan sits on over 80 acres of land and includes a 171,000 sq. ft. production building and warehouse. The production facility utilizes three high‐speed filling lines, four lyophilizers and a clinical fill line. The site also includes separate facilities for chemistry, sterility testing, and analytical methods development.

JHP has the capability to manufacture small‐scale clinical through large‐scale commercial products. JHP employs more than 330 staff in the USA in its manufacturing, product development, sales & marketing and corporate areas. For more information, please visit www.jhppharma.com.


'/>"/>
SOURCE JHP Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting
2. Optimer Pharmaceuticals Announces Presentation at Upcoming SHEA Annual Meeting Regarding Hospital CDI Patients at Risk of Recurrence and Mortality
3. Bellicum Pharmaceuticals Awarded $5.7 Million by the Cancer Prevention and Research Institute of Texas
4. Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer
5. Omthera Pharmaceuticals, Inc. to Present at the BIO Windhover/Pharmaceutical Strategic Outlook 2011 Conference
6. Reportlinker Adds Process Analytical Technologies for Pharmaceuticals: Global Markets
7. AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results
8. Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board
9. Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
10. Heygood, Orr & Pearson: Los Angeles Court Orders Watson Pharmaceuticals to Produce Documents, Provide Depositions in Fentanyl Patch Death Lawsuit
11. Inovio Pharmaceuticals Receives U.S. DOD Small Business Innovation Research Grant for Multi-Vaccine DNA Delivery Device Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... , May 5, 2016 Progra m ... trial of Oxitec , s mosquito in ... aegypti by 96 %   ... new plan to fight wild Aedes aegypti, the dangerous mosquito that ... the island of Grand Cayman .  MRCU, a global leader ...
(Date:5/5/2016)... , May 5, 2016 Research ... PET Imaging in Top 5 EU Markets"  report to their ... This report provides information on the current Positron Emission Tomography ... European Markets (T5 EU), which includes France ... , Spain and the ...
(Date:5/5/2016)... DUBLIN , May 5, 2016 /PRNewswire/ ... the addition of the  "Europe Thalassaemia Market ... to their offering.       (Logo: ... research Europe Thalassaemia Market and Competitive Landscape ... Thalassaemia pipeline products, Thalassaemia epidemiology, Thalassaemia market ...
Breaking Medicine Technology:
(Date:5/5/2016)... Kansas (PRWEB) , ... May 05, 2016 , ... ... that some macroalgae can use ultraviolet light A (UV-A) for photosynthesis, researchers Juntian ... of red, green, and brown seaweeds. The pair observed that when photosynthetically active ...
(Date:5/5/2016)... MS (PRWEB) , ... May 05, 2016 , ... ... medical conditions and Make-A-Wish grants the most heartfelt wishes of these children. ... rounds of medical treatment. President and CEO of Make-A-Wish Mississippi, Brent Wilson ...
(Date:5/5/2016)... ... 2016 , ... Long Island’s fastest growing comprehensive eye care provider, North ... Kathleen Van Valkenburg, MD as part of their ongoing effort to increase ophthalmic coverage ... managing partner of North Shore Eye Care. , “We are extremely proud to ...
(Date:5/5/2016)... ... May 05, 2016 , ... TIME for Kids and The ZAC Foundation ... new partnership to reach nearly 1 million children with important water safety messages before ... the leading cause of accidental death in children one to 6 years of age. ...
(Date:5/5/2016)... ... May 05, 2016 , ... In honor of National Nurses Week 2016, ... the United States to thank a nurse who's made a difference in their life. ... the American Red Cross of San Diego/Imperial Counties (up to $10,000) every time someone ...
Breaking Medicine News(10 mins):